GoPath Laboratories is a state-of-the-art CAP-accreditedCLIA-certified molecular diagnostic laboratory providing anatomic pathology, hematopathology, and hereditary cancer testing for clinicians, hospital systems, and pharmaceutical firms. Located just north of Chicago, our laboratory incorporates the latest technologies into our testing platforms including next-generation sequencing, cytogenetics, FISH, IHC, microarray analysis, and ddPCR. We specialize in cancer diagnostics through our OncoTarget®  NGS testing series, which include solid tumor and liquid biopsy analysis to detect and monitor a cancer’s genetic mutations. We also offer a wide-range of hereditary cancer testing through our GeneticsNowTM platform including BRCANow® for familial breast, ovarian and prostate cancer and LynchNowTM for Lynch syndrome.

Services: Our connectivity solution, GoPathConnectTM, will give you access to your patients’ lab tests 24/7 from any computer connected to the internet. GoPathConnectTM can be fully-integrated with any platform, workflow or EMR. In addition to our full-service global services, we also offer several opportunities for our clients to participate in the diagnostic process and realize additional revenue through our tech-only arrangements. GoPathConnectTM will give your pathologists access to high-quality images and data in real-time, allowing them to make accurate interpretations of every case from any location.

Innovation: As a group of physician scientists, we are committed to continuously researching and incorporating the latest technologies into our diagnostic workflow. Our scientists work rigorously to develop new molecular tests to ensure that our pathologists have the most accurate data at their disposal at all times. By having an in-house diagnostic team, billing department, and customer service staff, we can deliver fast TATs and respond to your needs quickly and efficiently, providing you with expert consultation and data as soon as it’s available. GoPath also welcomes collaboration inquires. Please contact us for additional information.

Education: Furthering education has always been part of GoPath’s mission. We are strong believers in providing patients with the most beneficial knowledge of their diagnosis and prognosis. We also strive to provide free education on topics that are most relevant to our clients through lectures, webinars, and a live case blog. We also have developed – an open hereditary gene mutation database established to give doctors, pathologists and researchers access to genetic testing data to study the impact of risk on associated syndromes and cancers. Our goal is to share information that can help others in their quest to better predict who is at risk for developing hereditary cancers.